Virtus LifeSci Financial Statements From 2010 to 2024
| BBC Etf | USD 26.12 0.05 0.19% |
Check Virtus LifeSci financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Virtus LifeSci's main balance sheet or income statement drivers, such as , as well as many indicators such as . Virtus financial statements analysis is a perfect complement when working with Virtus LifeSci Valuation or Volatility modules.
Virtus |
Virtus LifeSci Biotech ETF Beta Analysis
Virtus LifeSci's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Virtus LifeSci Beta | 0.99 |
Most of Virtus LifeSci's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virtus LifeSci Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Virtus LifeSci Biotech has a Beta of 0.99. This is much higher than that of the Virtus family and significantly higher than that of the Health category. The beta for all United States etfs is notably lower than that of the firm.
Virtus LifeSci Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Virtus LifeSci's current stock value. Our valuation model uses many indicators to compare Virtus LifeSci value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Virtus LifeSci competition to find correlations between indicators driving Virtus LifeSci's intrinsic value. More Info.Virtus LifeSci Biotech is second largest ETF in price to earning as compared to similar ETFs. It is fourth largest ETF in price to book as compared to similar ETFs fabricating about 0.04 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Virtus LifeSci Biotech is roughly 22.78 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Virtus LifeSci's earnings, one of the primary drivers of an investment's value.About Virtus LifeSci Financial Statements
Virtus LifeSci stakeholders use historical fundamental indicators, such as Virtus LifeSci's revenue or net income, to determine how well the company is positioned to perform in the future. Although Virtus LifeSci investors may analyze each financial statement separately, they are all interrelated. For example, changes in Virtus LifeSci's assets and liabilities are reflected in the revenues and expenses on Virtus LifeSci's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Virtus LifeSci Biotech. Please read more on our technical analysis and fundamental analysis pages.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:Check out the analysis of Virtus LifeSci Correlation against competitors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.